Home> Regulatory Information

Announcement of NMPA on Revising the Package Inserts of hydrocortisone injection and hydrocortisone sodium succinate for injection

CCFDIE|Updated: 2020-03-17

To further protect drug safety for the people, on March 17, 2020, NMPA issued an Announcement with decisions made to revise the [adverse reactions], [precautions] and other Entries on the package inserts of hydrocortisone injection and hydrocortisone sodium succinate for injection.